Search research articles
Contact Us
Filters
Showing results (11-20 of 94) with videos related to
Page
of 10
Sort By:
Cancer Treatment Reports
|
November 1, 1983
Current status of amsacrine (AMSA) combination chemotherapy programs in acute leukemia
Z A Arlin
Bone Marrow Transplantation
|
January 1, 1989
Mitoxantrone and amsacrine: two important agents for the treatment of acute myelogenous leukemia (AML) and acute lymphoblastic leukemia (ALL)
Z A Arlin
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1986
High-dose cytosine arabinoside with amsacrine for treatment of acute lymphoblastic leukemia
Z A Arlin
Blood
|
May 1, 1992
Cure in acute promyelocytic leukemia: now more readily achievable with less toxic therapy
Z A Arlin, T Ahmed
The American Journal of Medicine
|
March 1, 1984
Clustering of non-Hodgkin's lymphomas. A case study
A Israel, Z A Arlin
Cancer Treatment Reports
|
January 1, 1983
AMSA-induced seizures in patients with hypokalemia
A Mittelman, Z A Arlin
Leukemia
|
March 1, 1988
Bone marrow transplantation for chronic myelogenous leukemia: some thoughts about future prospects
T Ahmed, Z A Arlin
Leukemia
|
April 1, 1989
Can we increase the cure rate of adults with acute lymphoblastic leukemia?
Z A Arlin, E J Feldman
Cancer Chemotherapy and Pharmacology
|
December 1, 1982
Successful treatment of a patient with acute nonlymphoblastic leukemia (ANLL) and anthracycline cardiomyopathy with 4' (9-acridinylamino) methanesulfon-m-anisidide (AMSA)
M P Fanucchi, Z A Arlin
Advances in Internal Medicine
|
January 1, 1983
The treatment of acute nonlymphoblastic leukemia in adults
Z A Arlin, B D Clarkson
Page
of 10
Search research articles
Search
Showing results (11-20 of 94) with videos related to
Sort By:
Page
of 10
Cancer Treatment Reports
|
November 1, 1983
Current status of amsacrine (AMSA) combination chemotherapy programs in acute leukemia
Z A Arlin
Bone Marrow Transplantation
|
January 1, 1989
Mitoxantrone and amsacrine: two important agents for the treatment of acute myelogenous leukemia (AML) and acute lymphoblastic leukemia (ALL)
Z A Arlin
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1986
High-dose cytosine arabinoside with amsacrine for treatment of acute lymphoblastic leukemia
Z A Arlin
Blood
|
May 1, 1992
Cure in acute promyelocytic leukemia: now more readily achievable with less toxic therapy
Z A Arlin, T Ahmed
The American Journal of Medicine
|
March 1, 1984
Clustering of non-Hodgkin's lymphomas. A case study
A Israel, Z A Arlin
Cancer Treatment Reports
|
January 1, 1983
AMSA-induced seizures in patients with hypokalemia
A Mittelman, Z A Arlin
Leukemia
|
March 1, 1988
Bone marrow transplantation for chronic myelogenous leukemia: some thoughts about future prospects
T Ahmed, Z A Arlin
Leukemia
|
April 1, 1989
Can we increase the cure rate of adults with acute lymphoblastic leukemia?
Z A Arlin, E J Feldman
Cancer Chemotherapy and Pharmacology
|
December 1, 1982
Successful treatment of a patient with acute nonlymphoblastic leukemia (ANLL) and anthracycline cardiomyopathy with 4' (9-acridinylamino) methanesulfon-m-anisidide (AMSA)
M P Fanucchi, Z A Arlin
Advances in Internal Medicine
|
January 1, 1983
The treatment of acute nonlymphoblastic leukemia in adults
Z A Arlin, B D Clarkson
Page
of 10